Alkeran belongs to a class of drugs known as . It works by interfering with the DNA and RNA of cancer cells, which prevents them from dividing and ultimately leads to their death. While it is most well-known for treating multiple myeloma , it is also used for: Ovarian cancer Certain types of leukemia and lymphoma Neuroblastoma in children Its Role in Stem Cell Transplants

High doses can lead to "mucositis," making it important to follow your care team's dental and oral hygiene protocols.

These usually occur shortly after treatment and can last up to 48 hours.

Because it targets the bone marrow, it can temporarily lower your white blood cells, red blood cells, and platelets, increasing the risk of infection or fatigue. A Note on Lifestyle From MGUS to Multiple Myeloma Remission

Like most chemotherapy, Alkeran can cause side effects. Common experiences include:

Understanding Alkeran: A Standard in Myeloma Care Receiving a diagnosis that requires chemotherapy can be overwhelming, but understanding your treatment options is a powerful first step. (generic name: melphalan ) has been a foundational medication in the oncology world for decades, particularly for those navigating multiple myeloma. What is Alkeran?

Typically used for high-dose treatments during the transplant process.

One of the most critical uses of Alkeran today is in the process. Before a patient receives their healthy stem cells back, they are often given high-dose Alkeran intravenously. This "conditioning" therapy is designed to clear out remaining cancer cells in the bone marrow to make room for the new, healthy cells. Administration and Considerations Alkeran can be administered in two primary ways: